FDA Investigator Ying Xin Fan, PhD

Ying Xin Fan, PhD has conducted inspections on 7 sites in 4 countries as of 15 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
7
Last Inspection Date:
15 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Israel, Switzerland, China
FDA Investigators that have inspected at least one site in common with Ying Xin Fan, PhD:
Adam R Cooke, Alan R Condon, Anastasia G Lolas, Andrea Franco, Andrew M Barlow, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Ashar P Parikh, Ashutosh Rao, PhD, Bo Chi, PhD, Brandon C Heitmeier, Candace Y Gomez Broughton, Carl Lee, Carolyn A Renshaw, CDR Rochelle B Young, RPh, MSA, Charles L Zhou, Charles R Cote, RIC, Constance L Richard, Daniel L Zheng, Diane L Raccasi, Dorothy W Lee, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Edmund F Mrak, Jr, Eileen A Liu, Emmanuel Adu Gyamfi, PhD, Erika V Butler, Felix Maldonado, Frances Namuswe, PhD, Genoula K Ryan, George T Allen, Jr, Gerald B Seaborn, Jr, Gregory R Brinsley, Gwyn G Dickinson, Henry K Lau, Herbert M Corbello, Hung H Do, MS, Ivan E Reyes, Ivis L Negron, Jacob W Reynolds, Jacqueline Mdiaz Albertini, Jamie L Dion, Janis R Armedoriz, Jawaid Hamid, Jee Chung, PhD, Jeffrey M Watson, Jeffry A Bernhardt, Jianming Li, Joan A Loreng, Joel D Hustedt, John P Mistler, Jolanna A Norton, Jonathan G Matrisciano, Jorge L Guadalupe, Joslyn K Brunelle, PhD, Juhong Liu, PhD, Justin A Boyd, Kalavati Suvarna, PhD, Katherine Szestypalow, Kevin A Gonzalez, Kevin P Foley, Kula N Jha, Lance Mde Souza, MBA, Lane V Christensen, PhD, Laura Fontan, MS, Leonard H Lavi, Libia M Lugo, Lori B Wikstrom, Madushini Dharmasena, PhD, Maria Joselopez Barragan, PhD, Marie A Fadden, Marion Michaelis, Mary E Storch, Mary Jeanet Mcgarry, Megan A Haggerty, Meredith P Soehl, Investigator, Michael A Charles, Michael Shanks, MS, Michele Dougherty, PhD, Michelle Yclark Stuart, Mihaly S Ligmond, Monica Commerford, PhD, Nadeem I Chaudhry, Nicholas L Hunt, Paraluman S Leonin, Paula A Trost, Prabhu P Raju, Ramon E Martinez, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard H Penta, Richard Ledwidge (nmi), PhD, Robert Rodriguez, Rory K Geyer, Sandra A Hughes, Santos E Camara, Scott R Nichols, PhD, Sean R Marcsisin, Sherri J Jackson, Stacey S Degarmo, Stephen R Souza, Susan P Bruederle, Susan T Hadman, Tenzin Jangchup, Thomas J Arista, Thomas R Withers, Tiara Nbrown Crosen, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Wayne E Seifert, Wendy G Tan, PhD, William Hallett, PhD, William V Millar, Xiaokuang Lai, PhD, Yiyue Zhang (nmi), PhD, Zhong Li, PhD

Ying Xin Fan, PhD's Documents

Publish Date Document Type Title
December, 2016 FDA 483 KBI Biopharma, Inc. - Form 483, 2016-12-09
December, 2017 EIR BioMarin Pharmaceutical Inc. - EIR, 2017-12-14
October, 2019 FDA 483 Lonza AG - Form 483, 2019-10-18
May, 2023 FDA 483 Suzhou Union Biopharm Co., Ltd. - Form 483, 2023-05-26
September, 2020 FDA 483 Genzyme Corporation - Form 483, 2020-09-04
September, 2020 EIR Genzyme Corporation - EIR, 2020-09-04
December, 2017 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2017-12-14
January, 2014 FDA 483 Kingchem Laboratories Inc. - Form 483, 2014-01-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more